Search Within

Shakeel Modak

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Bone Marrow Transplant (7)
  3. Center for Hematologic Malignancies (7)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  5. Department of Medicine (7)
  6. GSK Faculty (7)

More Groups

People
  1. Nai-Kong Cheung (7)
  2. Katharine Hsu (6)
  3. Brian Kushner (5)
  4. Irene Cheung (4)
  5. Meighan Gallagher (4)
  6. Stephen Roberts (4)

More People

Years
  1. 2023 (1)
  2. 2018 (1)
  3. 2012 (3)
  4. 2011 (1)
  5. 2010 (1)
Publications
  1. Pediatric Blood and Cancer (3)
  2. Cancer Research (1)
  3. Journal of Clinical Investigation (1)
  4. Journal of Immunotherapy (1)
  5. OncoImmunology (1)
Publishers
  1. Wiley Periodicals, Inc (3)
  2. American Association for Cancer Research (1)
  3. American Society for Clinical Investigation (1)
  4. Landes Bioscience (1)
  5. Lippincott Williams & Wilkins (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gut microbiota associations with GD2/GD3 vaccine response in patients with high-risk neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Nguyen, C.; Cheung, I.; Kushner, B.; Mauguen, A.; Waters, N.; Dai, A.; Kivovich, V.; Littmann, E.; Harford, L.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S.; Gallagher, M.; Hsu, K.
    Journal of Immunotherapy (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save